Meridian Bioscience reported $76.2M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbott ABT:US $ 10928M 705M
Accelerate Diagnostics AXDX:US 3.12M 324K
Atrion ATRI:US 42.86M 162K
Becton, Dickinson and BDX:US $ 5135M 245M
Bio Rad Laboratories BIO:US $ 747.05M 31.12M
Cerus CERS:US $ 42.1M 4.34M
Genmark Diagnostics GNMK:US $ 50.08M 7.43M
Luminex LMNX:US $ 110.69M 0.7M
Meridian Bioscience VIVO:US $ 76.2M 12.69M
Myriad Genetics MYGN:US $ 167.3M 22.1M
Neogen NEOG:US $ 128.3M 0.88M
Orasure Technologies OSUR:US $ 53.92M 3.69M
Oxford Immunotec Global OXFD:US $ 19.44M 13.6M
Quidel QDEL:US $ 509.74M 333.13M
Rockwell Medical RMTI:US $ 15.99M 0.85M
Sientra SIEN:US $ 19.62M 0.48M
Staar Surgical STAA:US $ 58.35M 4.01M
Thermo Fisher Scientific TMO:US $ 9330M 57M
Trinity Biotech TRIB:US $ 25.84M 0.25M
Utah Medical Products UTMD:US $ 12.57M 1.61M